chr12-64691563-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_178169.4(RASSF3):āc.551A>Gā(p.Glu184Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000005 in 1,600,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000021 ( 0 hom., cov: 33)
Exomes š: 0.0000034 ( 0 hom. )
Consequence
RASSF3
NM_178169.4 missense
NM_178169.4 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 8.28
Genes affected
RASSF3 (HGNC:14271): (Ras association domain family member 3) The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.[supplied by OMIM, Jul 2003]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.924
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RASSF3 | NM_178169.4 | c.551A>G | p.Glu184Gly | missense_variant | 4/5 | ENST00000542104.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RASSF3 | ENST00000542104.6 | c.551A>G | p.Glu184Gly | missense_variant | 4/5 | 1 | NM_178169.4 | P2 | |
RASSF3 | ENST00000637125.1 | c.734A>G | p.Glu245Gly | missense_variant | 5/6 | 5 | A2 | ||
RASSF3 | ENST00000283172.8 | c.*40A>G | 3_prime_UTR_variant, NMD_transcript_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000209 AC: 3AN: 143538Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
143538
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251320Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135822
GnomAD3 exomes
AF:
AC:
2
AN:
251320
Hom.:
AF XY:
AC XY:
0
AN XY:
135822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1456764Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 725044
GnomAD4 exome
AF:
AC:
5
AN:
1456764
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
725044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000209 AC: 3AN: 143538Hom.: 0 Cov.: 33 AF XY: 0.0000143 AC XY: 1AN XY: 69848
GnomAD4 genome
AF:
AC:
3
AN:
143538
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
69848
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.551A>G (p.E184G) alteration is located in exon 4 (coding exon 4) of the RASSF3 gene. This alteration results from a A to G substitution at nucleotide position 551, causing the glutamic acid (E) at amino acid position 184 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;D
REVEL
Pathogenic
Sift
Uncertain
.;D;D
Sift4G
Uncertain
.;D;D
Polyphen
0.99
.;D;D
Vest4
0.97
MutPred
0.80
.;Loss of stability (P = 0.0289);Loss of stability (P = 0.0289);
MVP
0.62
MPC
0.44
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at